L'Oreal Acquires CeraVe and Two Other Skincare Brands from Valeant Pharmaceuticals for US$1.3 Billion
Goodmans LLP acted as Canadian counsel to L'Oréal USA Inc. (L'Oréal) in connection with its acquisition of Valeant Pharmaceuticals International, Inc.'s skincare brands CeraVe, AcneFree and Ambi for a cash purchase price of US$1.3 Billion.
CeraVe, AcneFree and Ambi will become part of L'Oréal's Active Cosmetics Division, which includes brands such as La Roche-Posay, Vichy and SkinCeuticals that are developed with and endorsed by health professionals - dermatologists, pediatricians and other physicians.
Featured Work
-
Mergers and Acquisitions
Browning West issues letter to Gildan Activewear’s board of directors outlining steps to restore stakeholder confidence
Goodmans LLP is acting for Browning West, LP in connection with issuing a letter to Gildan Activewear Inc. advocating for the reinstatement of its former CEO, Glenn Chamandy… -
Mergers and Acquisitions
Apotex to acquire Searchlight Pharma
Goodmans LLP is acting for Apotex Inc. in connection with its acquisition of Searchlight Pharma Inc… -
Mergers and Acquisitions
FASHIONPHILE acquires Two Authenticators Business
Goodmans LLP acted for FASHIONPHILE, LLC in connection with its purchase of the assets of Two Authenticators Inc… -
Mergers and Acquisitions
Bazaarvoice Inc. acquires Granify Inc.
Goodmans acted for Bazaarvoice Inc., a leading platform for full-funnel authentic user-generated content and social commerce, in relation with it’s acquisition of Granify Inc., an e-commerce company… -
Mergers and Acquisitions
Majority interest in Kensington Capital Partners Limited acquired by AGF Private Capital Inc.
Goodmans acted for Kensington Capital Partners in connection with AGF Private Capital Inc.'s acquisition of a majority interest in Kensington. Kensington is one of Canada’s leading alternative… -
Mergers and Acquisitions
Y. Dov Meyer and Seth Greenspan acquire remaining 92.5% stake in Terra Firma Capital Corporation
Goodmans acted for Y. Dov Meyer and Seth Greenspan in connection with their acquisition of the remaining 92.5% stake in Terra Firma Capital Corporation. The process commenced with a non-binding letter…